<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Inflammatory markers predict type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and relate to the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0009800'>Gestational diabetes</z:hpo> mellitus (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>) predicts type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and may be part of this syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>To examine the association of inflammatory markers with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>, we investigated total <z:chebi fb="0" ids="26667">sialic acid</z:chebi> (TSA) in women with and without previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> women with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> and a random sample of women from one center of the Brazilian Study of <z:hpo ids='HP_0009800'>Gestational Diabetes</z:hpo> were invited to return 7 years after their index pregnancy </plain></SENT>
<SENT sid="4" pm="."><plain>After an interview, an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test and anthropometry were performed </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 46 women with and 50 women without previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> completed the protocol </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Mean TSA was significantly higher in women with (71.8 +/- 11.1 mg/dl) than without (67.5 +/- 9.8 mg/dl) previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>In a linear regression model, TSA was 4 mg/dl (P &lt; 0.05) higher in women with previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>, after adjustment for BMI, fasting insulin sensitivity, and number of years spent in school </plain></SENT>
<SENT sid="8" pm="."><plain>In a similar model, current 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels were associated with higher TSA levels after adjustment for waist-to-hip ratio and the log of <z:chebi fb="4" ids="17855">triglycerides</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>TSA was strongly correlated with individual components and aggregates (r = 0.55, P &lt; 0.001) of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Increased TSA levels are associated with previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> and are strongly linked to the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>These findings in young women suggest that a <z:hpo ids='HP_0011010'>chronic</z:hpo> mild systemic <z:mp ids='MP_0001845'>inflammatory response</z:mp> is an early feature of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> may be a window for its investigation </plain></SENT>
</text></document>